We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
-7.67%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$2.31B
AUM Growth
-$305M
Cap. Flow
-$96.8M
Cap. Flow %
-4.19%
Top 10 Hldgs %
25.87%
Holding
249
New
58
Increased
56
Reduced
68
Closed
55

Top Buys

Rank Stock Value
1
ROP icon
Roper Technologies
ROP
+$37.9M
2
WELL icon
Welltower
WELL
+$35.9M
3
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$30.4M
4
APC
Anadarko Petroleum
APC
+$26.7M
5
PXD
Pioneer Natural Resource Co.
PXD
+$26.2M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$43.8M
2
BIIB icon
Biogen
BIIB
+$31.7M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$31.2M
4
PSX icon
Phillips 66
PSX
+$30.4M
5
ESL
Esterline Technologies
ESL
+$25.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.3%
2 Financials 18.12%
3 Communication Services 15.85%
4 Healthcare 12.87%
5 Technology 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
76
Humana
HUM
$47.6B
$7.98M 0.35%
44,566
+25,741
+137% +$4.76M
CERN
77
DELISTED
Cerner Corp
CERN
$7.61M 0.33%
126,870
+63,370
+100% +$4.14M
SWI
78
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
$7.49M 0.32%
190,800
+58,500
+44% +$2.41M
PGEN icon
79
Precigen
PGEN
$2.51B
$7.12M 0.31%
225,782
-295,803
-57% -$14.4M
SLRC icon
80
SLR Investment Corp
SLRC
$658M
$7.06M 0.31%
446,100
+109,400
+32% +$1.93M
UUP icon
81
Invesco DB US Dollar Index Bullish Fund
UUP
$322M
$7.03M 0.3%
280,004
-3,600
-1% -$90.7K
DVAX
82
DELISTED
Dynavax Technologies
DVAX
$7.01M 0.3%
285,858
-238,050
-45% -$6.74M
VCYT icon
83
Veracyte
VCYT
$3.23B
$6.61M 0.29%
1,408,236
-31,800
-2% -$303K
P
84
CALL
DELISTED
Pandora Media Inc
P
$6.4M 0.28%
+300,000
New +$5.26M
CVRS
85
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$6.22M 0.27%
2,013,254
+8,054
+0.4% +$29.1K
PRGO icon
86
Perrigo
PRGO
$1.88B
$6.17M 0.27%
39,208
-40,900
-51% -$7.5M
FWP
87
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$6.13M 0.27%
37,186
-700
-2% -$147K
ROL icon
88
Rollins
ROL
$16.2B
$5.89M 0.25%
492,903
-86,850
-15% -$1.1M
CVS icon
89
CVS Health
CVS
$121B
$5.87M 0.25%
+60,800
New +$6.39M
KERX
90
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$5.75M 0.25%
+1,632,300
New +$10.9M
CAA
91
DELISTED
CalAtlantic Group, Inc.
CAA
$5.48M 0.24%
137,020
+18,300
+15% +$799K
AZN icon
92
AstraZeneca
AZN
$251B
$5.39M 0.23%
+84,660
New +$5.57M
JAZZ icon
93
Jazz Pharmaceuticals
JAZZ
$15.6B
$5.36M 0.23%
40,346
-82,518
-67% -$14.2M
XLRN
94
DELISTED
Acceleron Pharma
XLRN
$5.24M 0.23%
210,597
-336,053
-61% -$10.1M
SAM icon
95
Boston Beer
SAM
$1.76B
$4.93M 0.21%
23,400
-46,924
-67% -$10.4M
SH icon
96
ProShares Short S&P500
SH
$920M
$4.91M 0.21%
+27,273
New +$4.7M
OTIC
97
DELISTED
Otonomy, Inc.
OTIC
$4.8M 0.21%
269,503
+103,600
+62% +$2.45M
CLNY
98
DELISTED
Colony Capital, Inc.
CLNY
$4.77M 0.21%
+243,900
New +$5.4M
ILMN icon
99
Illumina
ILMN
$33.6B
$4.72M 0.2%
27,629
-46,105
-63% -$9.32M
UAM
100
DELISTED
Universal American Corp
UAM
$4.66M 0.2%
681,673
-40,000
-6% -$324K
2 3
4
5 6

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Clough Capital Partners held 249 positions worth $2.31B, down 12% from $2.62B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Clough Capital Partners withdrew a net $96.8M in Q3 2015, closing 55 positions and reducing 68 holdings. Its most notable exit was Biogen, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 22% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Clough Capital Partners opened a new position in Roper Technologies worth $35.9M.

  • Clough Capital Partners's largest Q3 2015 buy was Roper Technologies: 229,060 shares worth $35.9M.
  • Clough Capital Partners added most to Welltower in Q3 2015, an estimated $35.9M increase.
  • Clough Capital Partners's biggest Q3 2015 reduction was Lam Research, cutting an estimated $43.8M.
  • Clough Capital Partners fully exited Biogen in Q3 2015, selling an estimated $31.7M.
  • Clough Capital Partners's ten largest holdings make up 26% of its $2.31B portfolio in Q3 2015.
  • Clough Capital Partners opened 58 new positions and closed 55 in Q3 2015.
  • Clough Capital Partners's portfolio value fell 12% quarter-over-quarter to $2.31B.

Based on Clough Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.